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Abstract
Osteoporosis is a multifactorial disease with great impact on morbid-
ity and mortality mainly in postmenopausal women. Although it is
recognized that factors related to life-style and habits may influence
bone mass formation leading to greater or lower bone mass, more than
85% of the variation in bone mineral density (BMD) is genetically
determined. The collagen type I alpha 1 (COLIA1) gene is a possible
risk factor for osteoporosis. We studied a population of 220 young
women from the city of São Paulo, Brazil, with respect to BMD and its
correlation with both COLIA1 genotype and clinical aspects. The
distribution of COLIA1 genotype SS, Ss and ss in the population
studied was 73.6, 24.1 and 2.3%, respectively. No association be-
tween these genotypes and femoral or lumbar spine BMD was de-
tected. There was a positive association between lumbar spine BMD
and weight (P<0.0001), height (P<0.0156), and body mass index
(BMI) (P<0.0156), and a negative association with age at menarche
(P<0.0026). There was also a positive association between femoral
BMD and weight (P<0.0001), height (P<0.0001), and BMI (P<0.0001),
and a negative correlation with family history for osteoporosis
(P<0.041). There was no association between the presence of allele s
and reduced BMD. We conclude that a family history of osteoporosis
and age at menarche are factors that may influence bone mass in our
population.
Correspondence
M. Lazaretti-Castro
Caixa Postal 20266
Vila Clementino
04034-970 São Paulo, SP
Brasil
E-mail: mlazaretti@endocrino.epm.br
Research supported by CNPq.
Publication supported by FAPESP.
Received November 28, 2001
Accepted May 24, 2002
Key words
• COLIA1
• Bone mineral density
• Risk factors
• Polymorphism
• Osteoporosis
Introduction
Osteoporosis is a common disease that
affects 30% of women and 12% of men at
some time in their lives (1). It is characterized
by reduced bone mineral density (BMD) and
deterioration of the microarchitecture of bone
tissue, leading to increased fragility and greater
risk of fracture (2). With the increase in life
expectancy among western human populations,
osteoporosis is becoming one of the major
public health problems, with great impact on
morbidity and mortality among elderly people.
A reduction of one standard deviation (SD) in
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BMD increases the risk of osteoporotic frac-
tures by 2.4 at different skeletal sites (3). BMD
is the best known predictor for the risk of
osteoporotic fractures. Both genetic and envi-
ronmental factors influence BMD. Therefore,
osteoporosis is considered a multifactorial dis-
order.
Initial evidence of the influence of ge-
netic factors on bone mass was reported by
Smith et al. (4), who found a greater concor-
dance between forearm BMD in monozy-
gotic twins as compared with dizygotic twins.
Family studies and twin studies have shown
that 75-85% of BMD is under genetic con-
trol (4-9). Due to the heterogeneity of its
presentation, osteoporosis should be consid-
ered a polygenic disease. Within this con-
text, several genes have been investigated,
including those that encode the vitamin D
receptor (10-12), the estrogen receptor
(10,12,13), transforming growth factor-ß
(10,14), interleukin-6 (10,14), the calcitonin
receptor (15), and collagen type I alpha 1
(COLIA1) (10,12-16).
Recently, several workers described a
strong association between COLIA1 gene
polymorphism and the occurrence of os-
teoporotic fractures. Collagen is the most
abundant protein in bone, type 1 being the
most frequent. It is constituted by two alpha
1 chains and one alpha 2 chain. These chains
have a similar spatial structure and are en-
coded by distinct genes located on chromo-
somes 17 and 7, respectively. Since several
mutations of the collagen type 1 gene have
been described in patients with osteogenesis
imperfecta, this gene has been considered a
strong candidate for the genetic regulation of
bone mass (17-19). Grant et al. (16) de-
scribed a polymorphism at a recognition site
for the transcription factor Sp1 in the COLIA1
gene, and found a greater expression of al-
lele “s” in patients with severe osteoporosis
and vertebral fractures when compared with
allele “S”. Uitterlinder et al. (20), investigat-
ing 1778 postmenopausal Dutch women,
found that those with the Ss genotype had
2% lower BMD at the femoral neck and
lumbar spine when compared with the SS
group. Such reduction was even more marked
in the ss group. Langdahl et al. (21) studied a
population of Danish men and women with
osteoporosis and found a 10-fold greater
expression of genotype ss in patients with
osteoporotic fractures as compared with
the control group. This reflected a relative
risk of 11.83 for osteoporotic vertebral frac-
tures in individuals with genotype ss. Those
findings suggest that COLIA1 gene poly-
morphism is associated with reduced bone
mass and increased risk of fractures, although
negative results have been reported (22-
24).
In Brazil, data on BMD and its relations
to genetic and environmental factors in a
population are rare and knowledge of such
characteristics is of fundamental importance
for a better understanding of osteometabolic
diseases and the elaboration of effective strat-
egies for disease prevention and treatment.
On the basis of the multifactorial behav-
ior of osteoporosis, the objective of the pres-
ent study was to measure BMD in a popula-
tion of young eumenorrheic women from
São Paulo city and to correlate the data with
both genetic (COLIA1 gene polymorphism)
and clinical aspects.
Material and Methods
This study was approved by the Medical
Ethics Committee and written consent was
obtained from each subject.
Subjects
Our surveyed population consisted of 220
healthy and eumenorrheic female volunteers
(mean age: 32.6 ± 5.8 years, range: 20 to 46),
who lived in the city of São Paulo and were
either staff members or students in the public
health area, classified according to self-re-
ported race (70.9% white, 5.3% black, 6.9%
oriental and 16.6% mixed origin - Cauca-
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sian/black). Our exclusion criteria were: pres-
ence of amenorrhea, a history of disease or
use of drugs that might interfere with bone
metabolism.
Method
Of the 220 volunteers, 195 answered a
questionnaire about personal data (age at
menarche, history of fractures, familial ante-
cedents for osteoporosis, use of contracep-
tives, current calcium intake, pregnancies,
lactation, schooling), habits (alcohol and
coffee intake, smoking, physical activity)
and also anthropometric features (weight,
height and body mass index, BMI).
A food inquiry intended to gather data on
consumption of dairy products was conducted.
On the basis of ingestion of dairy calcium,
the subjects were divided into three groups:
less than 500 mg/day, between 500 and 1000
mg/day, and more than 1000 mg/day. Alco-
hol intake was considered present when a
minimum of one dose (50 ml/50 g) of spirits
or 200 ml of fermented drink was consumed
daily. Smoking was considered present when
a minimum of 54 packs of cigarettes were
smoked yearly. The limits described above
were determined according to the lowest
consumption informed by a patient who self-
reported to be a smoker or an alcohol con-
sumer.
BMD was determined by dual energy X-
ray absorptiometry (Lunar DPX-L) at the lum-
bar spine (L2-L4) and femoral neck. The lum-
bar spine and femoral BMD of white women
(N = 132) were analyzed separately and by age
range (10-year intervals) to compare with BMD
values from the data bank of a DPX-Lunar
densitometer concerning American and Euro-
pean white women (UK and Scandinavia) (25)
and with BMD values for white Brazilian
women from another study (26).
Collagen type 1 polymorphism
Genomic DNA was extracted from leu-
kocytes of peripheral blood samples of the
220 subjects using a commercial kit (Pure-
gene DNA Isolation kits, Gentra Systems,
Inc., Minneapolis, MN, USA).
The G→T polymorphism at the Sp1 bind-
ing site of the COLIA1 gene was analyzed
according to the method described by Lang-
dahl et al. (21). To perform the polymerase
chain reaction (PCR), the primers 5'-
GTCCAGCCCTCATCCTGGCC-3' and 5'-
TAACTTCTGGACTATTTGCGGACTT
TTTGG-3' were used (21). The final volume
of PCR was 50 µl containing 400 ng of
genomic DNA, 10 pmol of each primer, 1.5
U of Taq DNA polymerase, 0.2 mM dNTPs,
1.5 mM MgCl2 and, 1X PCR buffer. PCR
was performed under the following condi-
tions: initial denaturation at 94ºC, followed
by 35 cycles at 94ºC for 1 min, 60ºC for 1
min, 72ºC for 1 min, and a final extension at
72ºC for 5 min using a PTC-200 thermocycler
(Poltier Thermal Cycler, MJ Research Inc.,
Watertown, MA, USA). The final product
was digested with 3 U of the restriction en-
zyme BalI (Amersham Pharmacia Biotech,
Little Chalfont, UK) overnight at 37ºC
(Techne DRL-Block BD-2D, Cambridge,
UK). The digestion products were submitted
to electrophoresis on 4% nuSieve GTG aga-
rose gel (FMC BioProducts, Rockland, ME,
USA), treated with ethidium bromide (0.5
µg/ml) and analyzed under ultraviolet light.
The PCR product containing allele s is
cleaved by the enzyme BalI, which identifies
the G→T substitution, resulting in a band of
246 bp compared with the non-cleaved S
allele, with a band of 264 bp (Figure 1).
Statistical analysis
The data are presented as means ± SD.
Comparisons of BMD and the other vari-
ables were made by the Student t-test and
chi-square test when appropriate. The Bon-
ferroni t-test was used for multiple compari-
sons of BMD among ethnic groups. The
level of significance was set at P<0.05.
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Results
Distribution of findings in the group studied
Data on age, anthropometric measure-
ments, lumbar spine and femoral BMD and
age at menarche are presented in Table 1.
The mean values for lumbar spine and
femoral BMD of the white women studied
(N = 132), divided into three distinct age
groups, are presented in Table 2. In the three
groups, both femoral neck and lumbar spine
BMD values were similar and did not change
with age. Comparison of the present younger
age group (20 to 29 years old) with similar
data from other studies showed that the aver-
age spine and femoral neck BMD was lower
than for the population studied by the manu-
facturer (25), consisting of Caucasian Ameri-
can and European women.
The comparison of our population with
another population of white Brazilian women
published by others (26) showed that our
subjects presented higher lumbar spine BMD
in the 40- to 49-year age range and higher
femoral neck BMD in the 30- to 39-year age
range (Table 2).
Correlation between BMD and the other
variables analyzed
Age and anthropometric measurements
(weight, height and BMI). Among the vari-
ous parameters measured, body weight cor-
related most strongly with lumbar spine BMD
(r = 0.46, P<0.001) and femoral BMD (r =
0.49, P<0.001). A statistically significant
correlation was also found between height
and both spinal (r = 0.17, P<0.015) and
femoral neck BMD (r = 0.34, P<0.001), and
264 bp
246 bp
M ss Ss SS
Figure 1. Digestion products of
the collagen type I alpha 1 gene
with Bal1. SS = homozygote nor-
mal; M = molecular size marker.
Table 2. Bone mineral density (BMD) data of the white women from this and other studies.
Age (years) Study population USA/Europe (Ref. 25) Other Brazilian study (Ref. 26)
N Femoral L2-L4 N (femoral/ L2-L4) Femoral L2-L4 N Femoral L2-L4
20-29 40 0.956 ± 0.09+ 1.160 ± 0.12# 739/672 0.998 ± 0.12 1.200 ± 0.12 27 0.950 ± 0.12 1.180 ± 0.14
30-39 77 0.965 ± 0.12* 1.200 ± 0.14 1067/916 0.973 ± 0.12 1.210 ± 0.12 47 0.890 ± 0.08 1.170 ± 0.11
40-49 15 1.185 ± 0.15+ 1.190 ± 0.15 1746/1630 0.946 ± 0.12 1.180 ± 0.12 126 0.890 ± 0.09 1.140 ± 0.12
Total 132 3552/3218 200
Data are reported as means ± SD (g/cm2).
+P<0.05 between femoral neck BMD of the population studied and American and European women;
*P<0.05 between femoral neck BMD of the population studied and Brazilian women;
#P<0.05 between lumbar spine BMD of the population studied and American and European women (one-way Bonferroni t-test).
Table 1. Age, age at menarche, anthropometric data and bone mineral density (BMD)
of the population studied.
Variable N Mean ± SD Range
Age (years) 220 32.6 ± 5.8 20-46
Menarche (years) 185 12.5 ± 1.6 9-17
Weight (kg) 195 61.7 ± 11.3 39-96
Height (m) 195 1.58 ± 0.1 1.44-1.85
BMI (kg/m2) 195 24.4 ± 4.2 18-40
BMD L2-L4 (g/cm2) 195 1.19 ± 0.14 0.75-1.63
BMD femoral (g/cm2) 195 0.97 ± 0.12 0.66-1.53
BMI = body mass index.
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between BMI and both spinal (r = 0.41,
P<0.001) and femoral neck BMD (r = 0.36,
P<0.001).
Schooling. In our study group, 91 (49%)
of the women had completed college, a fea-
ture closely related to the socioeconomic
status of this population. However, no sig-
nificant differences in lumbar spine or femo-
ral BMD were found between the women
with higher education and the remaining
group of the population.
Menarche, reproductive history, lacta-
tion and use of contraceptives. Age at me-
narche was negatively correlated with lum-
bar spine BMD (r = -0.22, P<0.002) but
showed no association with femoral BMD.
Ninety-nine subjects (53%) of our popula-
tion reported at least one episode of preg-
nancy; of these, 85 (85%) breastfed their
child for at least 3 months in at least one
pregnancy. Femoral and spinal BMD did
not differ between women with a positive
history of pregnancy or lactation and sub-
jects with no such history. One hundred and
eighteen (58%) women were using or had
used oral contraceptives for at least one year
in their lives. No association was found be-
tween previous or current use of oral contra-
ceptives and BMD at the sites analyzed.
Previous fractures and family history of
osteoporosis. Thirty-nine (21%) women had
a history of previous fractures, all of them
related to trauma and 39 (21%) had a family
history of osteoporosis. Femoral BMD (0.93
± 0.11 g/cm2) in the group with a positive
family history was significantly lower than
in the group with no family history (0.98 ±
0.11 g/cm2, P<0.041) and the difference re-
mained significant even after correction for
weight and height (data not shown). Lumbar
spine BMD was not influenced by the pres-
ence or absence of a family history of os-
teoporosis. No association was found be-
tween personal history of previous fractures
and lumbar spine or femoral BMD.
Calcium intake. The inquiry on consump-
tion of dairy products revealed that 80 (41%)
women consumed less than 500 mg/day, 90
(49.7%) 500 to 1000 mg/day and only 15
(8.3%) more than 1000 mg/day. Spine BMD
did not differ between these three groups
(1.20 ± 0.12, 1.19 ± 0.16 and 1.13 ± 0.13
g/cm2, respectively). A similar finding was
observed regarding femoral BMD (corre-
sponding BMD values: 0.98 ± 0.13, 0.97 ±
0.12 and 0.95 ± 0.13 g/cm2).
Physical activity. Previous physical ex-
ercise on a regular basis and at least twice a
week was reported by 107 (58%) subjects,
only 7 of whom were engaged in competitive
activities. Only 33 (17.7%) of the women
were practicing some kind of physical exer-
cise at the time of the study. However, no
association was found between femoral or
lumbar spine BMD values and previous or
current physical activity.
Habits (alcohol and coffee consumption
and smoking). Alcohol intake was found to
be rare in the population studied; no woman
reported consuming spirits and only 29
(15.7%) reported sporadic ingestion of fer-
mented drinks (maximum of one drink once
a week). One hundred and fifty-five (84.4%)
women denied drinking any alcoholic bever-
age. The femoral and lumbar spine BMD of
these women did not differ from women
who reported alcohol intake. Ingestion of at
least six cups of coffee a day (300 ml of
coffee) was reported by 56 (30.1%) women;
smoking more than three cigarettes/day was
reported by 48 (25.8%). No association was
found between drinking coffee or smoking
and lumbar spine or femoral BMD.
Ethnic group. Race distribution was as
follows: white (70.9%), black (5.3%), orien-
tal (6.9%) and mixed racial origin (Cauca-
sian/black) (16.6%). Black subjects presented
higher femoral and spinal BMD compared to
the other ethnic groups (Table 3).
COLIA1 gene polymorphism
The study of polymorphism at the trans-
cription factor Sp1 binding site of the
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Ss/ss groups showed similar clinical fea-
tures, except for ethnic distribution. The eth-
nic group distribution and spinal and femo-
ral BMD are presented in Table 4. The pres-
ence of allele s was rare among (2/13) orien-
tal women and absent among black women.
No significant differences were found
regarding BMD, age, body weight, height,
BMI or age at menarche (Table 5).
Discussion
The contribution of genetic factors to
bone mass is well documented. However, it
is not possible to ignore the interaction be-
tween heredity and both environmental and
life-style factors when studying determinants
of BMD. We first attempted to study the
association between vitamin D receptor poly-
morphism and BMD in a similar population.
Lazaretti-Castro et al. (27) investigated vita-
min D receptor gene polymorphism and BMD
in a population of young women from the
city of São Paulo and detected lower spinal
and femoral BMD in subjects with the BB
genotype when compared with the bb geno-
type.
Recent studies (16,20) found an associa-
tion between polymorphism for the binding
site of transcription factor Sp1 in the first
intron of the COLIA1 gene and BMD in two
different populations, making this gene a
candidate for osteoporotic risk factor. In the
population studied here, the distribution of
genotypes of the Sp1 binding site polymor-
phism in the COLIA1 gene showed a pre-
dominance of the SS genotype (73.6%) com-
pared with Ss (24.1%) and ss (2.3%). This
predominance has also been reported in the
literature (20-23).
We found no association between Sp1
binding site polymorphism and spine BMD
or femur BMD. A similar finding was also
described by Heegaard et al. (22), who re-
ported no association between COLIA1 gene
polymorphism and BMD in postmenopausal
Danish women. Similarly, Berg et al. (23)
COLIA1 gene indicated that the SS geno-
type was found in 162 (73.6%) of the 220
subjects, Ss in 53 (24.09%) and ss in only 5
(2.27%). The Ss and ss groups were ana-
lyzed together due to the small number of
individuals in the ss group. Both the SS and
Table 4. Racial distribution and bone mineral density (BMD) according to collagen type I
alpha 1 genotype.
Race SS Ss/ss Total
N L2-L4 Femoral N L2-L4 Femoral
White 94 1.18 ± 0.14 0.95 ± 0.12 38 1.19 ± 0.15 0.97 ± 0.10 132
Black 10 1.32 ± 0.20 1.11 ± 0.20 0 10
Oriental 12 1.23 ± 0.17 0.95 ± 0.90 1 1.14 0.90 13
Mixed 23 1.12 ± 0.13 1.02 ± 0.11 8 1.13 ± 0.21 0.94 ± 0.15 31
Data are reported as means ± SD (g/cm2). Chi-square of Pearson = 6.25, r = 0.0100.
Table 5. Age, age at menarche, anthropometric data and bone mineral density (BMD)
according to collagen type I alpha 1 genotype.
Variable Genotype P
SS Ss/ss
Age (years) 32.7 ± 6.13 32.3 ± 5.11 0.6301
Menarche (years) 12.5 ± 1.64 12.7 ± 1.47 0.3950
Height (m) 1.59 ± 0.06 1.60 ± 0.07 0.2698
Weight (kg) 62.2 ± 11.6 60.5 ± 10.3 0.3607
BMI (kg/m2) 24.7 ± 4.37 23.6 ± 3.42 0.1077
BMD L2-L4 (g/cm2) 1.20 ± 0.14 1.18 ± 0.158 0.5069
BMD femoral (g/cm2) 0.98 ± 0.13 0.96 ± 0.12 0.4126
Data are reported as means ± SD. BMI = body mass index.
Table 3. Lumbar spine and femoral neck bone mineral density (BMD) of the population
studied according to racial distribution.
Race L2-L4 Femoral
White (N = 132) 1.18 ± 0.14* 0.96 ± 0.11**
Black (N = 10) 1.32 ± 0.13* 1.11 ± 0.20**+
Oriental (N = 13) 1.22 ± 0.16 0.94 ± 0.09+
Mixed (N = 31) 1.18 ± 0.14 1.00 ± 0.12
Data are reported as means ± SD (g/cm2).
*P<0.05 for lumbar spine BMD between the white and black women;
**P<0.05 for femoral neck BMD between the white and black women;
+P<0.05 for femoral neck BMD between the oriental and black women (one-way
Bonferroni t-test).
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did not detect a correlation between COLIA1
gene polymorphism and BMD in healthy
children, adolescents and young adults. Simi-
lar results were described by Lidén et al. (24)
who analyzed this association in Swiss post-
menopausal women. Despite these negative
findings, this type of polymorphism deserves
our attention since in a recent meta-analysis
(13 studies including 3641 participants)
Efstathiadou et al. (28) demonstrated a posi-
tive association between COLIA1 gene poly-
morphism and the risk of vertebral fracture.
Group Ss risk was 1.25 times higher than
that of group SS, group ss risk was 1.68
times higher when compared to group SS,
and group ss risk was 1.35 times higher than
group Ss. It should be noted that most of the
populations studied in this meta-analysis were
older than ours. Nevertheless, Hustmyer et
al. (29), studying young American female
twins, also found no correlation between
BMD and COLIA1 gene polymorphism.
These data, taken together, suggest that the
COLIA1 genotypes are not related to peak
bone mass but may play a role in the rate of
bone loss during the aging process.
Our population was quite heterogeneous
with respect to distribution of ethnic groups,
a feature that reflects the historical heteroge-
neity and miscegenation of Brazilian popu-
lations. Our black women (N = 10) exclu-
sively expressed the SS genotype and had a
higher BMD when compared to the other
ethnic groups, irrespective of their genotype.
This finding should be viewed with caution,
since the number of black women in our
population was small. The BMD of our mixed
ethnic group did not differ significantly from
that of the white women. However, in Brazil
we have to admit that it is not easy to classify
individuals according to ethnic origin. Since
the majority of women in this group have
white and black ancestors, it might be pos-
sible to hypothesize that the bone protection
conferred by black ethnic origin may be lost
after miscegenation with whites. The spine
BMD of our white women differed from that
of the white Brazilian women studied by
Szejnfeld et al. (26) in the 40- to 49-year age
range; additionally, we also found a signifi-
cant difference in femoral BMD between
these two populations in the 30- to 39-year
age group.
An important finding was the fact that
white women 20-29 years of age presented
significantly lower spinal and femoral BMD
than age-matched white American and Eu-
ropean women (25). This difference has great
importance since most of the DEXA devices
used in Brazil consider as reference normal
range the European and American popula-
tions. Furthermore, although we defined one
of our groups as composed of white women,
it should be stressed again that we face some
difficulty in establishing the exact ethnic
profile of local populations. Additionally,
we should also take into account the fact that
the maximum age of the population included
in this study was 46 years and that our 40- to
46-year age range group was compared with
populations within the 40- to 49-year age
range. This may possibly explain the higher
values of lumbar spine BMD found in our
population compared with those reported by
Szejnfeld et al. (26).
We found a positive correlation between
spinal and femoral BMD and body weight,
height and BMI. This is in accordance with
Bauer et al. (30), who found body weight to
be a strong predictor of high bone mass.
Interestingly, we also detected an associa-
tion between a family history of osteoporo-
sis and reduced femoral BMD, as also re-
ported by Bauer et al. (30) and Cummings et
al. (31), who found lower bone mass values
in patients with a maternal history of verte-
bral fractures, forearm fractures or osteoporo-
sis. Age at menarche was found to be nega-
tively correlated with lumbar spine BMD, an
association suggested by Sowers et al. (32)
and Rosenthal et al. (33).
We found no correlation between BMD
and the other variables studied, such as re-
ported calcium and alcohol intake, smoking,
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physical activity, use of contraceptives, lac-
tation and pregnancy. The literature on these
parameters is controversial. However, our
data support the findings of Bauer et al. (30)
and Mazess and Barden (34), who likewise
did not find an association between BMD
and the variables described above. A similar
contradictory picture is found in the litera-
ture with respect to ingestion of alcohol and
BMD. The Framingham Study (35) reports a
positive correlation between ingestion of al-
coholic drinks and BMD. Conversely, Bauer
et al. (30) and the current study found no
association. With respect to coffee, our data
support the findings by Lloyd et al. (36), who
reported no correlation between drinking
coffee and BMD in a group of young Ameri-
can adolescents.
Our data indicate that COLIA1 gene poly-
morphism is not a good predictor for re-
duced BMD, and that parameters like body
weight, height, age at menarche and a family
history of osteoporosis may contribute as
risk factors for reduced BMD in the popula-
tion studied here.
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